Is multicenter collaborative research in clinical genetics dead and, if so, what killed it?
- 18 February 2005
- journal article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 134A (3) , 237-239
- https://doi.org/10.1002/ajmg.a.30619
Abstract
This study describes the course of a clinical trial designed to investigate the possible role of thrombophilic factors in limb reduction defects, which was abandoned after 1 year because lack of progress of the project through ethics review and the failure to make significant inroads in patient recruitment. Factors that are thought to have contributed to the failure are discussed, in the hope that others can avoid some of the pitfalls.Keywords
This publication has 10 references indexed in Scilit:
- Ethics review in researchBMJ, 2004
- Ethics review in researchBMJ, 2004
- How Do Institutional Review Boards Apply the Federal Risk and Benefit Standards for Pediatric Research?JAMA, 2004
- Comparison of requirements of research ethics committees in 11 European countries for a non-invasive interventional studyBMJ, 2004
- Ethics review roulette: what can we learn?BMJ, 2004
- Variations in experience in obtaining local ethical approval for participation in a multi‐centre studyQJM: An International Journal of Medicine, 2003
- Ethical approval for research involving geographically dispersed subjects: unsuitability of the UK MREC/LREC system and relevance to uncommon geneticJournal of Medical Ethics, 2001
- Maternal homozygosity for the commonMTHFR mutation as a potential risk factor for offspring with limb defectsAmerican Journal of Medical Genetics, 2001
- The new system of review by multicentre research ethics committees: prospective studyBMJ, 2000
- A pilot study of the possible role of familial defects in anticoagulation as a cause for terminal limb reduction malformationsClinical Genetics, 2000